CHARLES RIVER LABORATORIES INTERNATIONAL, INC. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $4.0B |
| Gross margin | — not reported |
| Operating income | $25.2M |
| Net income | −$144.3M |
| Diluted EPS | −$2.91 |
| Cash & equivalents | $213.8M |
| Total assets | $7.1B |
| Long-term debt | $2.1B |
Key takeaway
Charles River posted roughly $4.0 billion in revenue but only $25.2 million of operating income, a very thin margin for the year.
🔒 4 more takeaways in the full analysis
Beneath the surface
Net debt is substantial: with only $213.8 million in cash against $2.14 billion of debt instrument carrying amount (net of ~$12.5 million discount), the company carries roughly $1.9 billion in net debt despite a headline debt figure that looks manageable in isolation.
🔒 4 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 8 more findings — plus insider trades, activist stakes, and 8-K events for CRL.
Read the full analysis free Free account · 5 full analyses included · no card required